JNJ vs WST
By Alex · Tickerpine
Johnson & Johnson vs West Pharmaceutical Services, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | WST |
|---|---|---|
| Price | $285.75 | $416.42 |
| Market cap | $687.89B | $29.01B |
| P/E ratio | 43.4 | 46.7 |
| ROE | 20.02% | 21.23% |
| Profit margin | 16.20% | 18.81% |
| Revenue growth | 5.90% | 8.70% |
| Dividend yield | 1.88% | 0.25% |
| Beta | 0.20 | 1.14 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs WST in plain English
- JNJ is the bigger company — about 23.7× the market cap of WST.
- JNJ is cheaper on earnings (P/E 43.4 vs 46.7).
- WST earns a higher return on equity (21% vs 20%).
- WST is growing revenue faster (9% vs 6%).
- JNJ has the higher dividend yield (1.88% vs 0.25%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
WST return calculator
See what $1,000 in West Pharmaceutical Services, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.